证据与倡导之争:射频去神经术治疗慢性下腰痛与MINT试验
2017年JAMA发表的MINT试验纳入681例接受运动疗法的下腰痛患者,随机半数加用射频去神经术(RFD),结果显示RFD在运动疗法基础上无额外获益。2018年5位疼痛医学专家在RAPM发表「大胆论述」批评MINT试验,但未披露其与RFD设备厂商的顾问关系及在RAPM所属学会的任职。本文评论认为这些行为在RFD疗效评价中造成了不公平倾斜。
要点
- MINT试验显示RFD在运动疗法基础上对下腰痛无额外获益
- RAPM批评文章作者未披露学会任职及设备厂商顾问关系
- MINT研究者未对批评文章作出公开回应
核心结论
- 评论认为RAPM「大胆论述」作者及相关期刊的行为在RFD治疗下腰痛的评估与应用中不公平地倾斜了天平。
研究设计与样本
- 本文为评论文章,围绕2017年JAMA发表的MINT试验(前瞻性研究,681例下腰痛患者,全部接受运动疗法,随机半数加用RFD)及其后续发表的批评文章展开论述。
主要发现
- MINT试验中88%患者完成3个月随访,77%完成12个月随访。
- MINT试验中RFD在运动疗法基线之上未提供额外获益。
- RAPM「大胆论述」的5位作者中3位在利益冲突声明中报告为RFD设备厂商顾问,但未披露4/5为RAPM编委、5/5为拥有RAPM的美国区域麻醉与疼痛医学会现任官员。
- MINT试验研究者未对「大胆论述」的批评在任何发表渠道作出公开回应。
关键数值与推荐
- MINT试验:681例下腰痛患者全部接受运动疗法,随机半数加用RFD,RFD无额外获益。
- RAPM批评文章:5位作者中3位报告为RFD设备厂商顾问,未披露4/5为RAPM编委、5/5为学会现任官员。
临床怎么用
- 临床解读RFD治疗下腰痛的证据时,应关注原始试验结果及发表后评论背后可能存在的未披露利益关系。
局限性
- 本文为评论文章,未提供新的原始研究数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2017, JAMA: Journal of the American Medical Association published the results of the MINT trials, prospective research involving 681 patients, all of whom received exercise therapy for low back pain. Half of the patients were randomized to additionally receive radiofrequency denervation (RFD) treatment. 88% of patients completed the 3-month follow-up, and 77% completed the 12-month follow-up. In this context, RFD provided no added benefit over the baseline of exercise therapy. In 2018, five authors, all experts in pain medicine, published a 'Daring Discourse' article in the journal Regional Anesthesia and Pain Medicine (RAPM), criticizing the findings of the MINT trials. Although 3 of the 5 authors of the RAPM 'Daring Discourse' article reported in conflict of interest statements-as is appropriate-that they were consultants to corporations that produce RFD equipment, the authors failed to disclose that 4 of 5 are on the editorial board of RAPM and all 5 are current officers in the medical organization that owns RAPM: that is, the American Society of Regional Anesthesia and Pain Medicine. Noteworthy, there was no published response from the MINT trial investigators to the Daring Discourse criticisms, either in the aforementioned example or in downstream venues where some of the same Daring Discourse authors continued their widely disseminated criticisms of the JAMA/MINT trials report. We believe that these actions taken by the Daring Discourse authors and RAPM have unfairly tipped the scales in the evaluation and application of RFD treatment of low back pain. In our commentary, we discuss: (1) the challenges associated with using clinical trials to predict clinical efficacy, (2) appropriate and inappropriate uses of postpublication commentary on original research findings, (3) the use of inappropriate commentary (and related means) to alter clinical practice in the presence of contradictory research findings, and (4) potential conflicts of interest related to the authors' and Journal's publication of the unopposed MINT trials criticism.
引用
- Lanier WL, Neal JM. Evidence versus advocacy, as related to radiofrequency denervation in the treatment of chronic low back pain and the MINT trials. Reg Anesth Pain Med. 2020. PMID: 31831629. doi:10.1136/rapm-2019-100647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。